The following is a summary of “Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.

The findings of Furtado and colleagues support the general impression that intra-articular glucocorticoids might have greater efficacy and fewer side effects than systemically administered ...

A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving skin fibrosis in patients with early diffuse cutaneous systemic ...

A Japanese study finds avacopan effective in ANCA-associated vasculitis, with 90% achieving remission at 12 months. However, ...

In the 15-year risk analysis of prenatal exposure to systemic glucocorticoids, there was an increased risk of mental disorders, like ADHD.

Therefore, chronic stress or long-term hormone therapy can deplete the cellular ... induced proteasomal degradation of the ...

Aging Health. 2012;8(5):471-477. Osteoporosis associated with chronic glucocorticoid therapy appears to be an important medical problem, which may often be underestimated. Glucocorticosteroids ...

The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...

Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe ...